This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Biogen Idec Inc (BIIB)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 602.56M 570.72M 514.54M 759.60M
Receivables 1.08B 955.24M 813.33M 839.99M
Inventories 659.00M 447.37M 326.84M 289.07M
Other Current Assets 226.13M 136.01M 144.60M 22.12M
Total Current Assets 3.18B 3.24B 2.98B 2.54B
Property, Plant & Equipment, Gross 2.87B 2.68B 2.35B 2.41B
Accumulated Depreciation & Depletion 1.12B 941.10M 782.11M 767.17M
Property, Plant & Equipment, Net 1.75B 1.74B 1.57B 1.64B
Intangibles 4.47B 1.63B 1.61B 1.77B
Other Non-Current Assets 1.22B 2.31B 1.75B 991.30M
Total Non-Current Assets 8.68B 6.89B 6.07B 5.55B
Liabilities & Shareholder Equity
Total Assets 11.86B 10.13B 9.05B 8.09B
Accounts Payable 219.91M 204.00M 186.45M 162.53M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 179.68M 20.07M 45.94M 84.52M
Total Current Liabilities 1.76B 1.66B 912.89M 1.05B
Long Term Debt 592.43M 687.40M 1.06B 1.07B
Deferred Income Taxes 232.55M 217.27M 248.64M 200.95M
Other Non-Current Liabilities 659.23M 604.27M 400.28M 325.60M
Minority Interest 0.00 0.00 32.26M -106.70M
Total Non-Current Liabilities 1.48B 1.51B 1.71B 1.65B
Total Liabilities 3.24B 3.17B 2.62B 2.70B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 8.62B 6.96B 6.43B 5.40B
Common Par 128.00K 127.00K 128.00K 124.00K
Additional Paid In Capital 4.02B 3.85B 4.19B 3.90B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 6.35B 4.49B 3.11B 1.87B
Treasury Stock -1.72B -1.32B -839.90M -349.59M
Other Equity Adjustments -27.74M -55.30M -26.54M -21.61M
Total Capitalization 9.21B 7.65B 7.49B 6.46B
Total Equity 8.62B 6.96B 6.43B 5.40B
Total Liabilities & Stock Equity 11.86B 10.13B 9.05B 8.09B
Total Common Shares Outstanding 236.33M 236.58M 242.12M 240.54M
Preferred Shares 8.00K 8.00K 8.00K 8.00K
Treasury Shares 19.64M 17.66M 13.52M 7.66M
Basic Weighted Shares Outstanding 236.92M 237.94M 242.40M 252.31M
Diluted Weighted Shares Outstanding 238.31M 239.74M 245.03M 254.87M
Number of Employees 6850 5950 5000 4850
Number of Part-Time Employees 0 0 0 0

BIIB Biogen Idec Inc

Analysts Ratings for BIIB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 10 10 11
Moderate Buy 1 1 1 1
Hold 5 5 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

BIIB Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs